Copyright Reports & Markets. All rights reserved.

Global Therapeutic Protein Market Research Report 2019

Buy now

Table of Contents

    1 Therapeutic Protein Market Overview

    • 1.1 Product Overview and Scope of Therapeutic Protein
    • 1.2 Therapeutic Protein Segment by Type
      • 1.2.1 Global Therapeutic Protein Sales Growth Rate Comparison by Type (2021-2026)
      • 1.2.2 Monoclonal Antibodies
      • 1.2.3 Erythropoietin
      • 1.2.4 Insulin
      • 1.2.5 Interferon
      • 1.2.6 Human Growth Hormone
      • 1.2.7 Follicle Stimulating Hormone
      • 1.2.8 Blood Clotting Factors
    • 1.3 Therapeutic Protein Segment by Application
      • 1.3.1 Therapeutic Protein Sales Comparison by Application: 2020 VS 2026
      • 1.3.2 Pharmaceutical Companies
      • 1.3.3 Healthcare Service Providers
      • 1.3.4 Research Organizations
      • 1.3.5 Academic Research Institutes
    • 1.4 Global Therapeutic Protein Market Size Estimates and Forecasts
      • 1.4.1 Global Therapeutic Protein Revenue 2015-2026
      • 1.4.2 Global Therapeutic Protein Sales 2015-2026
      • 1.4.3 Therapeutic Protein Market Size by Region: 2020 Versus 2026

    2 Global Therapeutic Protein Market Competition by Manufacturers

    • 2.1 Global Therapeutic Protein Sales Market Share by Manufacturers (2015-2020)
    • 2.2 Global Therapeutic Protein Revenue Share by Manufacturers (2015-2020)
    • 2.3 Global Therapeutic Protein Average Price by Manufacturers (2015-2020)
    • 2.4 Manufacturers Therapeutic Protein Manufacturing Sites, Area Served, Product Type
    • 2.5 Therapeutic Protein Market Competitive Situation and Trends
      • 2.5.1 Therapeutic Protein Market Concentration Rate
      • 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
      • 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 2.7 Primary Interviews with Key Therapeutic Protein Players (Opinion Leaders)

    3 Therapeutic Protein Retrospective Market Scenario by Region

    • 3.1 Global Therapeutic Protein Retrospective Market Scenario in Sales by Region: 2015-2020
    • 3.2 Global Therapeutic Protein Retrospective Market Scenario in Revenue by Region: 2015-2020
    • 3.3 North America Therapeutic Protein Market Facts & Figures by Country
      • 3.3.1 North America Therapeutic Protein Sales by Country
      • 3.3.2 North America Therapeutic Protein Sales by Country
      • 3.3.3 U.S.
      • 3.3.4 Canada
    • 3.4 Europe Therapeutic Protein Market Facts & Figures by Country
      • 3.4.1 Europe Therapeutic Protein Sales by Country
      • 3.4.2 Europe Therapeutic Protein Sales by Country
      • 3.4.3 Germany
      • 3.4.4 France
      • 3.4.5 U.K.
      • 3.4.6 Italy
      • 3.4.7 Russia
    • 3.5 Asia Pacific Therapeutic Protein Market Facts & Figures by Region
      • 3.5.1 Asia Pacific Therapeutic Protein Sales by Region
      • 3.5.2 Asia Pacific Therapeutic Protein Sales by Region
      • 3.5.3 China
      • 3.5.4 Japan
      • 3.5.5 South Korea
      • 3.5.6 India
      • 3.5.7 Australia
      • 3.5.8 Taiwan
      • 3.5.9 Indonesia
      • 3.5.10 Thailand
      • 3.5.11 Malaysia
      • 3.5.12 Philippines
      • 3.5.13 Vietnam
    • 3.6 Latin America Therapeutic Protein Market Facts & Figures by Country
      • 3.6.1 Latin America Therapeutic Protein Sales by Country
      • 3.6.2 Latin America Therapeutic Protein Sales by Country
      • 3.6.3 Mexico
      • 3.6.3 Brazil
      • 3.6.3 Argentina
    • 3.7 Middle East and Africa Therapeutic Protein Market Facts & Figures by Country
      • 3.7.1 Middle East and Africa Therapeutic Protein Sales by Country
      • 3.7.2 Middle East and Africa Therapeutic Protein Sales by Country
      • 3.7.3 Turkey
      • 3.7.4 Saudi Arabia
      • 3.7.5 U.A.E

    4 Global Therapeutic Protein Historic Market Analysis by Type

    • 4.1 Global Therapeutic Protein Sales Market Share by Type (2015-2020)
    • 4.2 Global Therapeutic Protein Revenue Market Share by Type (2015-2020)
    • 4.3 Global Therapeutic Protein Price Market Share by Type (2015-2020)
    • 4.4 Global Therapeutic Protein Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

    5 Global Therapeutic Protein Historic Market Analysis by Application

    • 5.1 Global Therapeutic Protein Sales Market Share by Application (2015-2020)
    • 5.2 Global Therapeutic Protein Revenue Market Share by Application (2015-2020)
    • 5.3 Global Therapeutic Protein Price by Application (2015-2020)

    6 Company Profiles and Key Figures in Therapeutic Protein Business

    • 6.1 Amgen
      • 6.1.1 Corporation Information
      • 6.1.2 Amgen Description, Business Overview and Total Revenue
      • 6.1.3 Amgen Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.1.4 Amgen Products Offered
      • 6.1.5 Amgen Recent Development
    • 6.2 Abbott Laboratories
      • 6.2.1 Abbott Laboratories Therapeutic Protein Production Sites and Area Served
      • 6.2.2 Abbott Laboratories Description, Business Overview and Total Revenue
      • 6.2.3 Abbott Laboratories Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.2.4 Abbott Laboratories Products Offered
      • 6.2.5 Abbott Laboratories Recent Development
    • 6.3 AstraZeneca
      • 6.3.1 AstraZeneca Therapeutic Protein Production Sites and Area Served
      • 6.3.2 AstraZeneca Description, Business Overview and Total Revenue
      • 6.3.3 AstraZeneca Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.3.4 AstraZeneca Products Offered
      • 6.3.5 AstraZeneca Recent Development
    • 6.4 Baxter International
      • 6.4.1 Baxter International Therapeutic Protein Production Sites and Area Served
      • 6.4.2 Baxter International Description, Business Overview and Total Revenue
      • 6.4.3 Baxter International Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Baxter International Products Offered
      • 6.4.5 Baxter International Recent Development
    • 6.5 Boehringer Ingelheim
      • 6.5.1 Boehringer Ingelheim Therapeutic Protein Production Sites and Area Served
      • 6.5.2 Boehringer Ingelheim Description, Business Overview and Total Revenue
      • 6.5.3 Boehringer Ingelheim Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.5.4 Boehringer Ingelheim Products Offered
      • 6.5.5 Boehringer Ingelheim Recent Development
    • 6.6 Chugai Pharmaceutical
      • 6.6.1 Chugai Pharmaceutical Therapeutic Protein Production Sites and Area Served
      • 6.6.2 Chugai Pharmaceutical Description, Business Overview and Total Revenue
      • 6.6.3 Chugai Pharmaceutical Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.6.4 Chugai Pharmaceutical Products Offered
      • 6.6.5 Chugai Pharmaceutical Recent Development
    • 6.7 Diasome Pharmaceuticals
      • 6.6.1 Diasome Pharmaceuticals Therapeutic Protein Production Sites and Area Served
      • 6.6.2 Diasome Pharmaceuticals Description, Business Overview and Total Revenue
      • 6.6.3 Diasome Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.4.4 Diasome Pharmaceuticals Products Offered
      • 6.7.5 Diasome Pharmaceuticals Recent Development
    • 6.8 Eli Lilly
      • 6.8.1 Eli Lilly Therapeutic Protein Production Sites and Area Served
      • 6.8.2 Eli Lilly Description, Business Overview and Total Revenue
      • 6.8.3 Eli Lilly Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.8.4 Eli Lilly Products Offered
      • 6.8.5 Eli Lilly Recent Development
    • 6.9 GeneScience Pharmaceuticals
      • 6.9.1 GeneScience Pharmaceuticals Therapeutic Protein Production Sites and Area Served
      • 6.9.2 GeneScience Pharmaceuticals Description, Business Overview and Total Revenue
      • 6.9.3 GeneScience Pharmaceuticals Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.9.4 GeneScience Pharmaceuticals Products Offered
      • 6.9.5 GeneScience Pharmaceuticals Recent Development
    • 6.10 Generex Biotechnology
      • 6.10.1 Generex Biotechnology Therapeutic Protein Production Sites and Area Served
      • 6.10.2 Generex Biotechnology Description, Business Overview and Total Revenue
      • 6.10.3 Generex Biotechnology Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.10.4 Generex Biotechnology Products Offered
      • 6.10.5 Generex Biotechnology Recent Development
    • 6.11 Genentech
      • 6.11.1 Genentech Therapeutic Protein Production Sites and Area Served
      • 6.11.2 Genentech Therapeutic Protein Description, Business Overview and Total Revenue
      • 6.11.3 Genentech Therapeutic Protein Sales, Revenue and Gross Margin (2015-2020)
      • 6.11.4 Genentech Products Offered
      • 6.11.5 Genentech Recent Development

    7 Therapeutic Protein Manufacturing Cost Analysis

    • 7.1 Therapeutic Protein Key Raw Materials Analysis
      • 7.1.1 Key Raw Materials
      • 7.1.2 Key Raw Materials Price Trend
      • 7.1.3 Key Suppliers of Raw Materials
    • 7.2 Proportion of Manufacturing Cost Structure
    • 7.3 Manufacturing Process Analysis of Therapeutic Protein
    • 7.4 Therapeutic Protein Industrial Chain Analysis

    8 Marketing Channel, Distributors and Customers

    • 8.1 Marketing Channel
    • 8.2 Therapeutic Protein Distributors List
    • 8.3 Therapeutic Protein Customers

    9 Market Dynamics

    • 9.1 Market Trends
    • 9.2 Opportunities and Drivers
    • 9.3 Challenges
    • 9.4 Porter's Five Forces Analysis

    10 Global Market Forecast

    • 10.1 Global Therapeutic Protein Market Estimates and Projections by Type
      • 10.1.1 Global Forecasted Sales of Therapeutic Protein by Type (2021-2026)
      • 10.1.2 Global Forecasted Revenue of Therapeutic Protein by Type (2021-2026)
    • 10.2 Therapeutic Protein Market Estimates and Projections by Application
      • 10.2.1 Global Forecasted Sales of Therapeutic Protein by Application (2021-2026)
      • 10.2.2 Global Forecasted Revenue of Therapeutic Protein by Application (2021-2026)
    • 10.3 Therapeutic Protein Market Estimates and Projections by Region
      • 10.3.1 Global Forecasted Sales of Therapeutic Protein by Region (2021-2026)
      • 10.3.2 Global Forecasted Revenue of Therapeutic Protein by Region (2021-2026)
    • 10.4 North America Therapeutic Protein Estimates and Projections (2021-2026)
    • 10.5 Europe Therapeutic Protein Estimates and Projections (2021-2026)
    • 10.6 Asia Pacific Therapeutic Protein Estimates and Projections (2021-2026)
    • 10.7 Latin America Therapeutic Protein Estimates and Projections (2021-2026)
    • 10.8 Middle East and Africa Therapeutic Protein Estimates and Projections (2021-2026)

    11 Research Finding and Conclusion

      12 Methodology and Data Source

      • 12.1 Methodology/Research Approach
        • 12.1.1 Research Programs/Design
        • 12.1.2 Market Size Estimation
        • 12.1.3 Market Breakdown and Data Triangulation
      • 12.2 Data Source
        • 12.2.1 Secondary Sources
        • 12.2.2 Primary Sources
      • 12.3 Author List

      The global Therapeutic Protein market is valued at US$ xx million in 2020 is expected to reach US$ xx million by the end of 2026, growing at a CAGR of xx% during 2021-2026.
      This report focuses on Therapeutic Protein volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Therapeutic Protein market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan etc.
      Market Segment Analysis
      The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
      Segment by Type, the Therapeutic Protein market is segmented into
      Monoclonal Antibodies
      Erythropoietin
      Insulin
      Interferon
      Human Growth Hormone
      Follicle Stimulating Hormone
      Blood Clotting Factors

      Segment by Application
      Pharmaceutical Companies
      Healthcare Service Providers
      Research Organizations
      Academic Research Institutes

      Global Therapeutic Protein Market: Regional Analysis
      The Therapeutic Protein market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.
      The key regions covered in the Therapeutic Protein market report are:
      North America
      U.S.
      Canada
      Europe
      Germany
      France
      U.K.
      Italy
      Russia
      Asia-Pacific
      China
      Japan
      South Korea
      India
      Australia
      Taiwan
      Indonesia
      Thailand
      Malaysia
      Philippines
      Vietnam
      Latin America
      Mexico
      Brazil
      Argentina
      Middle East & Africa
      Turkey
      Saudi Arabia
      U.A.E
      Global Therapeutic Protein Market: Competitive Analysis
      This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.
      The major players in global Therapeutic Protein market include:
      Amgen
      Abbott Laboratories
      AstraZeneca
      Baxter International
      Boehringer Ingelheim
      Chugai Pharmaceutical
      Diasome Pharmaceuticals
      Eli Lilly
      GeneScience Pharmaceuticals
      Generex Biotechnology
      Genentech

      Buy now